COVID-19, shock séptico refractario y terapia extracorpórea de purificación sanguínea con OXIRIS® / Management of refractory septic shock with blood purification therapy using a special filter: report of one case
Rev. méd. Chile
;
150(2): 266-270, feb. 2022. ilus, tab
Article
in Spanish
| LILACS
| ID: biblio-1389636
ABSTRACT
Sepsis is one of the leading causes of death in critically ill patients with COVID-19 and blood purification therapies have a role to immunomodulate the excessive inflammatory response and improve clinical results. One of the devices designed for these therapies is the oXiris® filter, allowing to perform renal replacement therapy combined with selective adsorption of endotoxins and cytokines. We report a 55-year-old male with COVID who developed a septic shock secondary to a sepsis caused by Pseudomona aeruginosa, refractory to the usual management. A veno-venous continuous hemofiltration was started using the oXiris® filter for 48 hours. Subsequently, there was an improvement in clinical perfusion parameters and a reduction in inflammatory markers. The patient was discharged from the intensive care one month later.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Shock, Septic
/
Sepsis
/
COVID-19
Limits:
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2022
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital Carlos Van Buren/CL
Similar
MEDLINE
...
LILACS
LIS